Moderna Inc. Headquarters in Cambridge, Massachusetts, March 26, March 26.
Adam Glancman | Bloomberg | Getty images
Modern Its experienced on Monday Influenza vaccine based on MRNA The evening had a strong immune response than testing, which has been tested late, and the company will promote a separate combination of product and company and Covib jab.
Moderna in May Express an application volunteer Covid-19 and influenza are designed to approve its utilities, its plans to use effective influenza phase data. After this decision is discussed by the Department of Food and Drugs, he is the Secretary General of Health and Human Resources Robert F. Kennedy JR, there are outstanding vaccine skeptic acidts.
The company plans to resubmit an application for new data, which is scheduled to re-send an application for a vaccine, and at the end of this year, the head of the company’s research and development departments.
If the regulators approve the influenza vaccine, the company can restart the combination, and the HOZ. According to him, the specialist expects approval for two frames next year, reviews will be considered next year.
Monday, Moderna’s shares have increased by more than 5%, on Monday.
The embarrassed wise said that the “helping a health care system” has facilitated the workload of doctors and nurses and reducing the workload between patients.
The company seems to be Frontrunner in the competition Pfizer and Novavava bringing a combination to the market. The specialty does not have predictions for their own products, and there are no forecasts of hazhe, cowd, influenza and respiratory syndicate.
“Clearly,” we will allow our products to find our own contribution, – he said.
After more than 40,000 children aged 50 and older courts, more than 40,000 adults, they were appointed to take a single dose called MERNA-1010, called Modna-1010 or a standard competing vaccine. The shooting of specialties in general studies, 26.6% more than another vaccine.
Also, MRNO-1010 JAB also showed strong efficiency for each of the shooting, including A / H1N1, A / H3N2 and Victoria. The profit of the vaccine in the specialist said that people of different ages are consistent in terms of people with different risk factors and influenza vaccination status.
In adults over 65, shooting was 27.4% more efficient from standard influenza vaccine.
The effects of efficiency are an important stage to reduce influenza to large adults, “said Stefan Bankel, General Director of Wordera. “The severity of the influenza season indicates the need for more efficient vaccines.”
Modern intelligence Seasonal diseases and outpatient visits of influenza from centers of disease control and preventure show that the virus is higher than 2024 to 2025 by 2024. More than 600,000 Americans Last year was hospitalized due to influenza due to influenza, CDC reports.
MRNO-1010 vaccine security data corresponded to the previous results of the other three stages.
Moderna’s shares have exceeded 30% to Monday, because Monday, CLEANING CHANGE OF THE VACCINISH’S QUICK OF THE US’S AUDJUM. Administration in May Cautioned to Halusca has delayed a bird flu vaccine for contracts and people.
When asked about an unknown regulatory environment in the United States, Hoje Howge has close contact with FDA to understand how its requirements and how to meet them.
“I believe that we have a very clear way,” he said.
